MD Anderson Media
Chapter 1: Introduction to Prenatal Diagnosis
Overview of Prenatal Diagnosis
Involves screening and diagnostic tests to identify abnormalities.
Screening Tests: Identify higher risk individuals but do not provide a diagnosis.
Diagnostic Tests: Confirm diagnosis of abnormalities if present.
Evolution of Recommendations
Historically focused on women of advanced maternal age (AMA).
ACOG now recommends prenatal diagnosis for all pregnant women, offering various tests regardless of age.
Common Diagnostic Tests
Used to detect chromosomal and phenotypic abnormalities.
Not all chromosomal abnormalities are detectable via standard cytogenetic analysis.
Microarray Analysis: Useful for identifying smaller deletions/duplications that chromosomal analysis might miss.
Uni parental Disomy (UPD)
Refers to inheritance of both chromosomes from one parent for a given homologous pair.
Limitations in Diagnostic Testing
Cytogenetic analysis might miss low-level mosaicism—abnormal cell lines not represented in an amniotic sample.
Single gene disorders can be diagnosed if there is evidence of parental carrier status.
Testing Samples in Prenatal Diagnosis
Amniotic Fluid: Commonly used for chromosome analysis.
Chorionic Villi Sampling (CVS): Involves testing placenta samples; limited to placental cells.
Fetal Blood Sampling: Rarely performed, typically when detailed confirmation is needed.
Samples from cystic hygromas or fetal urine can also be used for analysis under specific conditions.
Procedural Considerations
Risks of invasive procedures must be communicated to patients.
Decisions often made based on previous pregnancy histories or abnormal screening results.
Chapter 2: FISH or Trisomy Tests
FISH (Fluorescence in situ Hybridization) Testing
Quick test to detect aneuploidy of chromosomes, commonly used in prenatal settings.
Results can be returned rapidly, usually within the same day.
Complementary to confirmatory cytogenetics; not standalone.
Limitations of FISH Testing
Not all chromosomal abnormalities are covered by the panel; potential for false-negative results.
Technical artifacts could affect results, especially in poorly collected samples.
Every positive test should be confirmed with further chromosome analysis.
Examples of Clinical Cases
Case studies where false positives/negatives in FISH testing highlighted the importance of confirmatory tests.
Chapter 3: Understanding Chromosomes
Karyotyping and Chromosomal Analysis
Essential for visualizing chromosomes and detecting abnormalities.
Cases demonstrate how translocations can complicate interpretations of results.
Recurrence Risks
Varies by genetic abnormalities; translocations significantly raise risk rates compared to trisomies.
Chapter 4: Mosaicism and Analysis
Definition of Mosaicism
Presence of two or more genetically different cell lines in one individual.
More common in prenatal samples derived from placental tissues versus fetal tissues.
Reporting Standards
Level one mosaicism: rarely reported.
Level two mosaicism: moderate workup required.
Level three mosaicism: always reported due to significant implications.
Chapter 5: Addressing Abnormal Results
Handling Inconclusive Findings
Assessing cases with conflicting results to determine clinical significance.
Follow-ups often include parental karyotyping for accurate risk assessments.
Clinical Implications for Parents
Counseling is crucial; outcomes can influence important decisions.
Chapter 6: Parental Considerations in Genetic Testing
Uni parental Disomy (UPD)
Can have significant clinical consequences, including unmasking of recessive genes.
Clinical Examples of UPD Cases
Instances where UPD played a role in genetic conditions observed in offspring.
Chapter 7: Normal and Abnormal Cell Analysis
Diagnostic Challenges
Examples of abnormal findings from karyotype results leading to potential mix-ups.
Importance of additional tests (e.g., SRY FISH) to clarify gender anomalies.
Chapter 8: Conclusion
Summary of Prenatal Diagnostics
Highlights the complexity and psychological weight of prenatal testing.
Genetic counseling connects clinical findings with patient decisions.